Patent AnalyticsExaminers
Rankings

Company or institution

Adimab, LLC

77 applicationsfiled 2006 to 2026

Allowance rate
88%
+13 pts vs the USPTO range 78% to 94%
Rejections before allowance
1.1
−0.5 vs the USPTO
Months to first action
20.0 mo
+1.4 vs the USPTO
Needed an RCE
21%
−6 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07K Peptides53 apps
C12N Microorganisms or enzymes10 apps
G01N Investigating or analysing materials4 apps
A61P Therapeutic activity of compounds4 apps
C40B 3 apps

Art units

163915 apps
164414 apps
16488 apps
OPAP8 apps
16417 apps
16464 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19618543INFLUENZA ANTIBODIES AND METHODS OF USE THEREOF2026-08-26Pending00n/a
19447385HIGH AFFINITY ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR GENERATION AND USE2026-01-13Pending00n/a
19484392ANTI-CD28 ANTIBODIES AND METHODS RELATED THERETO2025-11-14Pending00n/a
15700550Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15133965Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15800246Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15960591Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15758724Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15236705Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15837985Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 77 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in